GlassScriptPhysician profile
James Scott Petit
NPI 1720516560
$9,342.38
in general payments reported to CMS, 2019-2025
31 companies · $3,388 in 2025
The $3,388 reported for 2025 was more than what 86% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $689 · 2020: $345 · 2021: $256 · 2022: $581 · 2023: $1,174 · 2024: $2,909 · 2025: $3,388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,234 · Education: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,233.69 |
| Education | $237.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,322.12 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $1,166.10 | 2019-2025 | Dupixent |
| Sun Pharmaceutical Industries INC. | $729.04 | 2022-2025 | Ilumya, Blu-U, Odomzo |
| Amgen INC. | $630.36 | 2022-2025 | Otezla, Otezla |
| Ucb, INC. | $616.69 | 2021-2025 | Bimzelx, Cimzia |
| Novartis Pharmaceuticals Corporation | $571.02 | 2019-2025 | |
| Lilly USA, LLC | $492.19 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Pfizer INC. | $439.37 | 2019-2025 | |
| Arcutis Biotherapeutics, INC. | $419.19 | 2024-2025 | Zoryve |
| Genzyme Corporation | $412.40 | 2019-2025 | |
| Dermavant Sciences, INC. | $407.34 | 2023-2024 | Vtama |
| Incyte Corporation | $352.27 | 2021-2025 | Opzelura, Opzelura |
| Mayne Pharma Commercial LLC | $318.12 | 2022-2025 | |
| Janssen Biotech, INC. | $276.38 | 2019-2025 | Tremfya, Stelara, Simponi |
| E.R. Squibb & Sons, L.L.C. | $264.69 | 2024-2025 | Sotyktu |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Leo Pharma INC. | $185.15 | 2022-2025 | Adbry, Spevigo, Anzupgo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $158.34 | 2023-2025 | Spevigo |
| Celgene Corporation | $124.99 | 2019 | |
| Organon LLC | $102.81 | 2025 | Vtama, Hadlima |
| Galderma Laboratories, L.P. | $85.40 | 2024-2025 | Nemluvio |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $70.12 | 2023-2025 | Jublia, Cabtreo, Duobrii |
| Almirall LLC | $40.69 | 2024 | Klisyri |
| Botanix Sb INC | $20.50 | 2025 | Sofdra |
| Fresenius Kabi USA, LLC | $18.54 | 2023 | Sodium Chloride |
| Verrica Pharmaceuticals INC. | $18.02 | 2025 | Ycanth |
| Prugen, INC. Pharmaceuticals | $17.57 | 2019 | |
| Biofrontera INC. | $17.45 | 2023 | Ameluz, Xepi, Bf-Rhodoled |
| Kerecis Limited | $17.43 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Helsinn Therapeutics (U.S.), INC. | $16.69 | 2022 | |
| Cashflow Solutions, LLC | $15.80 | 2023 | Pcd-52 737a (US) White, Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt |
| Allergan, INC. | $15.60 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Petit listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.